Newsfeeds - Spark Newswire

2 minute read

Zuora Sees Q1 EPS $0.00-$0.01 Vs $0.00 Est.; Q1 Revenue $101M-$103M Vs $102.75M Est.; FY24 EPS $0.07-$0.11 Vs $0.08 Est.; FY24 Revenue $428M-$440M Vs $432.01M Est.

Today, 8:02 AM

Financial Outlook: As of March 1, 2023, we are providing guidance for the first quarter and full fiscal year 2024 based on current market conditions and expectations. We emphasize that

ZUO

1 minute read

Zuora Q4 EPS $(0.04) Beats $(0.06) Estimate, Sales $103.04M Beat $100.23M Estimate

By Happy Mohamed

Today, 8:02 AM

Zuora (NYSE:ZUO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 300 percent decrease over losses of $(0.01) per share from the same period

ZUO

11 minute read

Earnings

Earnings Scheduled For March 1, 2023

By Benzinga Insights

Today, 8:02 AM

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

AAN

1 minute read

Lake Street Initiates Coverage On Zuora with Buy Rating, Announces Price Target of $11

By Benzinga Newsdesk

Today, 8:02 AM

Lake Street analyst Jacob Stephan initiates coverage on Zuora (NYSE:ZUO) with a Buy rating and announces Price Target of $11.

ZUO

1 minute read

Canaccord Genuity Maintains Buy on Zuora, Lowers Price Target to $15

By Benzinga Newsdesk

Today, 8:02 AM

Canaccord Genuity analyst Joseph Vafi maintains Zuora (NYSE:ZUO) with a Buy and lowers the price target from $20 to $15.

ZUO

9 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 8:02 AM

During Thursday's trading, 138 companies set new 52-week lows.

ACHL

1 minute read

Why Zuora Shares Hit A New 52-Week Low Today

By Henry Khederian

Today, 8:02 AM

Zuora Inc (NYSE: ZUO) shares are trading lower by 20.21% to $5.74 after the company issued fourth-quarter and FY23 revenue guidance below estimates. What Happened?

ZUO

4 minute read

Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 8:02 AM

Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.

ALVO

13 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 8:02 AM

Wednesday saw 219 companies set new 52-week lows.

$APE

2 minute read

United Natural Foods, Ollie’s Bargain, Smith & Wesson Brands And Some Other Big Stocks Moving Lower On Wednesday

By Lisa Levin

Today, 8:02 AM

U.S. stocks traded mostly lower, with the Nasdaq Composite dropping over 60 points on Wednesday. Here are some big stocks recording losses in today’s session.

BFLY